Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)

Market Cap	19.97B
Revenue (ttm)	3.00B
Net Income (ttm)	1.43B
Shares Out	1.20B
EPS (ttm)	1.23
PE Ratio	13.62
Forward PE	8.31
Dividend	0.40 (2.40%)
Ex-Dividend Date	Nov 8, 2024

Volume	10,801,495
Average Volume	9,143,931
Open	16.84
Previous Close	16.68
Day's Range	16.59 - 16.84
52-Week Range	12.49 - 19.98
Beta	0.50
RSI	51.40
Earnings Date	Apr 19, 2025

About SHE:000623

Jilin Aodong Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China. The company provides various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, tonic medicines, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It is also involved in the highway construction and toll collection businesses; animal husbandry activities; manufacture of specialty chemicals; production and supply of heat...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1957
• Employees: 5,646
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000623

Financial Performance

In 2023, SHE:000623's revenue was 3.45 billion, an increase of 20.25% compared to the previous year's 2.87 billion. Earnings were 1.46 billion, a decrease of -18.02%.